00620nas a2200241   4500000000100000000000100001008004100002100001400043700001600057700001400073700001500087700001700102700001500119700001100134700002500145700001700170700001400187700001400201245013100215300001100346490000700357022001400364       2012                            d1 aS. Toovey1 aE. Prinssen1 aC. Rayner1 aB. Thakrar1 aR. Dutkowski1 aA. Koerner1 aT. Chu1 aA. Sirzen-Zelenskaya1 aM. Britschgi1 aS. Bansod1 aB. Donner00aPost-marketing assessment of neuropsychiatric adverse events in influenza patients treated with oseltamivir: an updated review  a826-480 v29  a0741-238x